Elderly Independent Patients With Non Small Cell Lung Cancer (NSCLC)
Status:
Completed
Trial end date:
2009-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine duration before progression of first-line treatment
chemotherapy following erlotinib in second-line comparing erlotinib in first-line following
chemotherapy in second-line in old patients with none small cell lung cancer.